Authors: Fu Z; Department of Obstetrics and Gynecology, Department of Pharmacology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Chen S; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Zhu Y; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA., Zhang D; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA., Xie P; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Jiao Q; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA., Chi J; Department of Obstetrics and Gynecology, Department of Pharmacology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Xu S; Department of Obstetrics and Gynecology, Department of Pharmacology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Xue Y; Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Lu X; Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Song X; Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA., Cristofanilli M; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Gradishar WJ; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Kalinsky K; Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Yin Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Zhang B; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Wan Y; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.

Source: Science advances [Sci Adv] 2023 Jan 06; Vol. 9 (1), pp. eadd6626. Date of Electronic Publication: 2023 Jan 06.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

MeSH Terms: Immunotherapy*/methods , Triple Negative Breast Neoplasms*, Humans ; CD8-Positive T-Lymphocytes ; Proteolysis ; Ubiquitin-Protein Ligases

Authors: Smith DM; Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA., Schafer JR; Kiadis Pharma, Sanofi, 1105BP Amsterdam, Netherlands., Tullius B; Advent Health for Children, Orlando, FL 32804, USA., Witkam L; Kiadis Pharma, Sanofi, 1105BP Amsterdam, Netherlands., Paust S; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.

Source: Science translational medicine [Sci Transl Med] 2023 Jan 04; Vol. 15 (677), pp. eabl5278. Date of Electronic Publication: 2023 Jan 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

MeSH Terms: Killer Cells, Natural* , Immunotherapy*, Antiviral Agents

Authors: Qin C; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Tian DS; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Zhou LQ; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Shang K; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Dong MH; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., You YF; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Xiao J; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Xiong Y; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Wang W; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Pang H; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Guo JJ; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Cai SB; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Wang D; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Li CR; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Zhang M; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Bu BT; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Wang W; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China. wwang@tjh.tjmu.edu.cn.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China. wwang@tjh.tjmu.edu.cn.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Jan 04; Vol. 8 (1), pp. 5. Date of Electronic Publication: 2023 Jan 04.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Neuromyelitis Optica*/therapy , Neuromyelitis Optica*/etiology, Humans ; Female ; Adult ; Middle Aged ; Aged ; Male ; Immunoglobulin G

Authors: Wang G; Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Zhang Z; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Zhong K; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Wang Z; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Yang N; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Tang X; Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Li H; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Lu Q; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Wu Z; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Yuan B; Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Zheng M; Department of Otolaryngology, Head and Neck Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Cheng P; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China., Tong A; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China. Electronic address: aipingtong@scu.edu.cn., Zhou L; Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China. Electronic address: liangxue_zhou@126.com.

Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Jan 04; Vol. 31 (1), pp. 134-153. Date of Electronic Publication: 2022 Sep 02.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

MeSH Terms: Chemokine CXCL11*/genetics , Glioblastoma*/therapy , Oncolytic Virotherapy* , Receptors, Chimeric Antigen*/genetics , Immunotherapy, Adoptive* , Brain Neoplasms*/therapy, Animals ; Mice ; Adenoviridae/genetics ; Cell Line, Tumor ; Tumor Microenvironment ; Xenograft Model Antitumor Assays

Authors: Jacoby E; Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Toren A; Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Gefen R; Department of Pediatric Hemato-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel., Shapira A; Department of Pediatric Hemato-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel., Arad-Cohen N; Department of Pediatric Hemato-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.

Source: Harefuah [Harefuah] 2023 Jan; Vol. 162 (1), pp. 15-18.

Publication Type: Case Reports; English Abstract; Journal Article

Journal Info: Publisher: Israel Medical Association Country of Publication: Israel NLM ID: 0034351 Publication Model: Print Cited Medium: Print ISSN: 0017-7768 (Print) Linking ISSN: 00177768 NLM ISO Abbreviation: Harefuah Subsets: MEDLINE

MeSH Terms: Burkitt Lymphoma* , Immunotherapy, Adoptive* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Receptors, Chimeric Antigen*, Female ; Humans ; Antigens, CD19 ; Cell- and Tissue-Based Therapy ; Ovary/pathology

Authors: Coyle L; Commissioning Editor, Future Science Group, Unitec House, 2 Albert Place, N3 1QB, London, UK.

Source: Immunotherapy [Immunotherapy] 2023 Jan; Vol. 15 (1), pp. 1-4. Date of Electronic Publication: 2023 Jan 26.

Publication Type: Journal Article

Journal Info: Publisher: Future Medicine Country of Publication: England NLM ID: 101485158 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-7448 (Electronic) Linking ISSN: 1750743X NLM ISO Abbreviation: Immunotherapy Subsets: MEDLINE

MeSH Terms: Anniversaries and Special Events* , Immunotherapy*, Humans

Authors: Badaracco J; BluePath Solutions, Los Angeles, California., Gitlin M; BluePath Solutions, Los Angeles, California., Keating SJ; Bristol Myers Squibb, Princeton, New Jersey. Electronic address: scott.j.keating@gmail.com.

Source: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jan; Vol. 29 (1), pp. 59.e1-59.e6. Date of Electronic Publication: 2022 Oct 19.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Lymphoma, Large B-Cell, Diffuse*, Humans ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/therapy ; Models, Economic ; Monte Carlo Method

Authors: de Vries NL; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., van de Haar J; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands., Veninga V; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Chalabi M; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Ijsselsteijn ME; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., van der Ploeg M; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., van den Bulk J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Ruano D; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., van den Berg JG; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Haanen JB; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Zeverijn LJ; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Geurts BS; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., de Wit GF; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Battaglia TW; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus MC, Rotterdam, The Netherlands., Schumacher TN; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Wessels LFA; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands., Koning F; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., de Miranda NFCC; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. n.f.de_miranda@lumc.nl., Voest EE; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. e.voest@nki.nl.; Oncode Institute, Utrecht, The Netherlands. e.voest@nki.nl.

Source: Nature [Nature] 2023 Jan; Vol. 613 (7945), pp. 743-750. Date of Electronic Publication: 2023 Jan 11.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

MeSH Terms: Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/genetics , Colonic Neoplasms*/immunology , Colonic Neoplasms*/therapy , Histocompatibility Antigens Class I*/genetics , Histocompatibility Antigens Class I*/immunology , Immune Checkpoint Inhibitors*/pharmacology , Immune Checkpoint Inhibitors*/therapeutic use , Immunotherapy* , Receptors, Antigen, T-Cell, gamma-delta*/immunology , T-Lymphocytes*/immunology , Genes, MHC Class I*/genetics, Humans ; beta 2-Microglobulin/deficiency ; beta 2-Microglobulin/genetics ; DNA Mismatch Repair/genetics ; Receptors, KIR ; Cell Line, Tumor ; Organoids ; Antigen Presentation

SCR Disease Name: Turcot syndrome

Authors: Bouche G; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom; The Anticancer Fund, Meise, Belgium. Electronic address: g.bouche@ucl.ac.uk., Langley R; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Rush H; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Parmar M; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Gilbert DC; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jan; Vol. 178, pp. 88-90. Date of Electronic Publication: 2022 Oct 31.

Publication Type: Letter

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

MeSH Terms: Immune Checkpoint Inhibitors* , Immunotherapy*, Humans ; Clinical Trials as Topic

Authors: Galtier J; Université de Paris, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Paris., Vercellino L; Assistance Publique-Hôpitaux de Paris, Hopital Saint-Louis, Medecine Nucléaire, Paris., Chartier L; LYSARC, Statistique, Pierre-Benite., Olivier P; Medecine Nucleaire Centre Hospitalier Universitaire Nancy., Tabouret-Viaud C; Medecine Nucleaire Centre Leclerc, Dijon., Mesguich C; Medecine nucléaire, Centre Hospitalier Universitaire de Bordeaux, Bordeaux., Di Blasi R; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Paris., Durand A; Service d'Hématologie Clinique, Centre Hospitalier Universitaire Dijon, INSERM UMR1231, Dijon., Raffy L; Medecine nucléaire, Centre Hospitalier Universitaire de Bordeaux, Bordeaux., Gros FX; Service d'hématologie clinique, Centre Hospitalier Universitaire de Bordeaux., Madelaine I; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Pharmacie, Paris., Meignin V; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, service de pathologie., Mebarki M; Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Therapie cellulaire, Paris., Rubio MT; Hématologie, Centre Hospitalier Universitaire, Vandoeuvre-les-Nancy., Feugier P; Hématologie, Centre Hospitalier Universitaire, Vandoeuvre-les-Nancy., Casasnovas O; Service d'Hématologie Clinique, Centre Hospitalier Universitaire Dijon, INSERM UMR1231, Dijon., Meignan M; LYSA-IM, Hopital Henri Mondor, Créteil., Thieblemont C; Université de Paris, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Paris. catherine.thieblemont@aphp.fr.

Source: Haematologica [Haematologica] 2023 Jan 01; Vol. 108 (1), pp. 171-180. Date of Electronic Publication: 2023 Jan 01.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

MeSH Terms: Lymphoma, Large B-Cell, Diffuse*/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse*/therapy , Lymphoma, Large B-Cell, Diffuse*/metabolism , Positron-Emission Tomography*/methods , Immunotherapy*, Humans ; Lactate Dehydrogenases ; Positron Emission Tomography Computed Tomography ; Prognosis ; Retrospective Studies ; T-Lymphocytes/metabolism

Authors: Kwon M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid. mi.kwon@salud.madrid.org., Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra., Reguera JL; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla., Corral LL; Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca., Morales RH; Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia., Ortiz-Maldonado V; Department of Hematology, Hospital Clínic, Barcelona., Guerreiro M; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia., Caballero AC; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona., Domínguez MLG; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria., Pina JMS; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid., Mussetti A; Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, Barcelona., Sancho JM; Department of Hematology, Hospital Universitari Germans Trias i Pujol, Instituto Catalán de Oncología, Josep Carreras Research Institute, Badalona., Bastos-Oreiro M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid., Catala E; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra., Delgado J; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla., Henriquez HL; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria., Sanz J; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia., Calbacho M; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid., Bailén R; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid., Carpio C; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra., Ribera JM; Department of Hematology, Hospital Universitari Germans Trias i Pujol, Instituto Catalán de Oncología, Josep Carreras Research Institute, Badalona., Sureda A; Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, Barcelona., Briones J; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona., Hernandez-Boluda JC; Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia., Cebrián NM; Department of Hematology, Hospital Clínic, Barcelona., Martin JLD; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Universidad Complutense de Madrid., Martín A; Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca., Barba P; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra.

Source: Haematologica [Haematologica] 2023 Jan 01; Vol. 108 (1), pp. 110-121. Date of Electronic Publication: 2023 Jan 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Lymphoma, Large B-Cell, Diffuse*/therapy, Humans ; Adaptor Proteins, Signal Transducing ; Antigens, CD19 ; Retrospective Studies

Authors: Eccleston A

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2023 Jan; Vol. 22 (1), pp. 16.

Publication Type: News

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Receptors, Chimeric Antigen*/genetics, Humans ; T-Lymphocytes ; Receptors, Antigen, T-Cell

Authors: Zhang R; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China., Wang H; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China., Xiao J; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China., Lu J; Hubei Aerospace Hospital, Xiaogan, Hubei, China., Li M; Hubei Aerospace Hospital, Xiaogan, Hubei, China., Zhou Y; Hubei Aerospace Hospital, Xiaogan, Hubei, China., Sun H; Hubei Aerospace Hospital, Xiaogan, Hubei, China., Liu L; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China., Huang T; Hubei Aerospace Hospital, Xiaogan, Hubei, China., Zhao Q; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China.

Source: DNA and cell biology [DNA Cell Biol] 2023 Jan; Vol. 42 (1), pp. 27-42. Date of Electronic Publication: 2022 Dec 29.

Publication Type: Journal Article

Journal Info: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9004522 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7430 (Electronic) Linking ISSN: 10445498 NLM ISO Abbreviation: DNA Cell Biol Subsets: MEDLINE

MeSH Terms: Caveolin 1*/genetics , Esophageal Neoplasms*/genetics , Esophageal Neoplasms*/therapy , Immunotherapy*, Humans ; Adjuvants, Immunologic ; Tumor Microenvironment

Authors: Hsu MA; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., Okamura SM; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., De Magalhaes Filho CD; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., Bergeron DM; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., Rodriguez A; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., West M; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., Yadav D; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., Heim R; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA., Fong JJ; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA. jerry.fong@rakuten-med.com., Garcia-Guzman M; Rakuten Medical, Inc., Translational Sciences, 11080 Roselle Street, San Diego, CA, 92121, USA.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Jan; Vol. 72 (1), pp. 151-168. Date of Electronic Publication: 2022 Jul 01.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

MeSH Terms: Immunotherapy*/methods , Neoplasms*/therapy, Humans ; Animals ; Mice ; Phototherapy/methods ; Disease Models, Animal ; Cell Line, Tumor ; Tumor Microenvironment

Authors: Yao Z; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Gu B; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Zhang Y; Department of Hematology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, No 62, Huaihai Road (S.), Huai'an, China., Qi J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Chen J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Xu Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China., Chen F; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Ma X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Miao M; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Xue S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Tang X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China., Han Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China., Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China., Sun A; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Yu L; Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China., Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. wudepei@suda.edu.cn.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. wudepei@suda.edu.cn.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China. wudepei@suda.edu.cn.; State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China. wudepei@suda.edu.cn., Wang Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. yingwang1977@hotmail.com.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. yingwang1977@hotmail.com.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China. yingwang1977@hotmail.com.

Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Jan; Vol. 58 (1), pp. 103-105. Date of Electronic Publication: 2022 Oct 17.

Publication Type: Letter

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

MeSH Terms: Bridge Therapy*/methods , Hematopoietic Stem Cell Transplantation* , Immunotherapy, Adoptive*/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Receptors, Chimeric Antigen*, Humans ; Antigens, CD19/therapeutic use ; Philadelphia Chromosome

Authors: Nishino H; Department of Surgery, University of California San Diego, San Diego, CA, USA.; Department of Surgery, VA San Diego Healthcare System, San Diego, CA, USA.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Turner MA; Department of Surgery, University of California San Diego, San Diego, CA, USA.; Department of Surgery, VA San Diego Healthcare System, San Diego, CA, USA., Amirfakhri S; Department of Surgery, University of California San Diego, San Diego, CA, USA.; Department of Surgery, VA San Diego Healthcare System, San Diego, CA, USA., Lwin TM; Department of Surgery, University of California San Diego, San Diego, CA, USA.; Department of Surgical Oncology, Dana Farber Cancer Center, Boston, MA, USA., Hosseini M; Department of Pathology, University of California San Diego, San Diego, CA, USA., Singer BB; Institute of Anatomy, Medical Faculty, University of Duisburg-Essen, Essen, Germany., Hoffman RM; Department of Surgery, University of California San Diego, San Diego, CA, USA.; AntiCancer, Inc., San Diego, CA, USA., Bouvet M; Department of Surgery, University of California San Diego, San Diego, CA, USA. mbouvet@ucsd.edu.; Department of Surgery, VA San Diego Healthcare System, San Diego, CA, USA. mbouvet@ucsd.edu.; UCSD Moores Cancer Center, La Jolla, CA, USA. mbouvet@ucsd.edu.

Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Jan; Vol. 30 (1), pp. 626-627.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

MeSH Terms: Immunotherapy*/methods , Pancreatic Neoplasms*/surgery , Pancreatic Neoplasms*/therapy, Animals ; Mice

SCR Disease Name: Pancreatic Carcinoma

Authors: Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. maziarzr@ohsu.edu., Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.

Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2023 Jan; Vol. 20 (1), pp. 5-6.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Lymphoma, Large B-Cell, Diffuse*, Humans ; Antigens, CD19

Authors: Zhong M; Department of Biopharmaceuticals, School of Life Science and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou, China; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China., Chalbatani GM; Department of Immunology, Mayo Clinic, Scottsdale, AZ 85259, USA., Deng M; Department of Biopharmaceuticals, School of Life Science and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou, China; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China., Li Q; Department of Biopharmaceuticals, School of Life Science and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou, China., Gharagouzloo E; Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran, Iran., Hamblin MR; Laser Research Centre, University of Johannesburg, Doornfontein 2028, South Africa., Suarez ER; Center for Natural and Human Sciences, Federal University of ABC, Santo Andre, SP 09210-580, Brazil., Hu L; Department of Biopharmaceuticals, School of Life Science and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, China. Electronic address: xnhulili@gdpu.edu.cn., Wang D; Department of Biopharmaceuticals, School of Life Science and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, China. Electronic address: twangdd@gdpu.edu.cn.

Source: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Jan 01; Vol. 180, pp. 106331. Date of Electronic Publication: 2022 Nov 13.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

MeSH Terms: Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/therapy , Receptors, Chimeric Antigen*/genetics , Immunotherapy, Adoptive*/methods, Animals ; Humans ; Mice ; Cell Line, Tumor ; Molecular Docking Simulation ; T-Lymphocytes ; Vascular Endothelial Growth Factor A ; Vascular Endothelial Growth Factor Receptor-2/genetics ; Xenograft Model Antitumor Assays

Authors: Fang Y; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Liu W; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Tang Z; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Ji X; Department of Biochemistry , School of Life Sciences , Fudan University , Shanghai , P.R. China., Zhou Y; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China.; Department of Immunology and Pathogenic Biology , School of Basic Medical Sciences , Shanghai University of Traditional Chinese Medicine , Shanghai , P. R. China., Song S; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China.; Department of Biochemistry and Molecular , School of Basic Medical Sciences , Fudan University , Shanghai , P.R. China., Tian M; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China.; Department of General Surgery , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Tao C; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Huang R; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Zhu G; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Jiang X; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Gao J; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Qu W; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Wang H; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Zhou P; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Wu X; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Jin L; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Sun H; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Ding Z; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Peng Y; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Zhao S; Institute of Metabolism and Integrative Biology , Obstetrics & , Gynecology Hospital of Fudan University , Shanghai , P.R. China., Zhou J; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Fan J; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China., Xu W; Shanghai Key Laboratory of Medical Epigenetics , International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology) , Institutes of Biomedical Sciences , Shanghai Fifth People's Hospital , Fudan University , Shanghai , P.R. China., Shi Y; Department of Liver Surgery , Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) , Liver Cancer Institute , Zhongshan Hospital , Fudan University , Shanghai , P.R. China.

Source: Hepatology (Baltimore, Md.) [Hepatology] 2023 Jan 01; Vol. 77 (1), pp. 109-123. Date of Electronic Publication: 2022 Feb 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE

MeSH Terms: Carcinoma, Hepatocellular*/therapy , Immunotherapy* , Liver Neoplasms*/therapy , Monocarboxylic Acid Transporters*/genetics , Monocarboxylic Acid Transporters*/metabolism, Animals ; Mice ; Lactic Acid/metabolism ; Tumor Microenvironment ; Humans

Authors: Schlüter J; Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Erlangen 91054, Germany., Cunningham S; Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Erlangen 91054, Germany. Electronic address: sarah.cunningham@uk-erlangen.de., Zimmermann R; Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Erlangen 91054, Germany., Achenbach S; Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Erlangen 91054, Germany., Kramer R; Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen 91054, Germany., Erdmann M; Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen 91054, Germany., Beckmann M; Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen 91054, Germany., Heinzerling L; Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen 91054, Germany; Department of Dermatology and Allergology, Ludwig-Maximilian University, Munich 80539, Germany., Hackstein H; Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Erlangen 91054, Germany.

Source: Immunobiology [Immunobiology] 2023 Jan; Vol. 228 (1), pp. 152311. Date of Electronic Publication: 2022 Dec 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8002742 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3279 (Electronic) Linking ISSN: 01712985 NLM ISO Abbreviation: Immunobiology Subsets: MEDLINE

MeSH Terms: Immune Checkpoint Inhibitors*/adverse effects , Immunotherapy* , Platelet Activation*/drug effects, B7-H1 Antigen ; Programmed Cell Death 1 Receptor ; Humans